CORONA Remedies Limited (CORONA) — Financial Results | 3 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Audio recording of Q1 FY27 earnings conference call made available
💡 Investor Takeaway
The call recording provides direct access to management commentary on unaudited results.

CORONA Remedies Limited announced that the audio recording of its Q1 FY27 earnings conference call for the quarter ended June 30, 2026 is now available on its website at https://www.coronaremedies.com/q1-fy27-epcar, following the filing of unaudited financial results and in compliance with SEBI Listing Obligations and Disclosure Requirements.

📄 View Original Announcement (PDF)

About CORONA Remedies Limited (CORONA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹10,869.98 Cr

View full CORONA stock details →

📡 Get AI alerts when CORONA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CORONA — Free

📊 More CORONA filings

See all CORONA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CORONA files new disclosures

Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CORONA — Free

Free account · 2 AI queries/day